Literature DB >> 8865312

Local absorption kinetics of levofloxacin from intestinal tract into portal vein in conscious rat using portal-venous concentration difference.

Y Fujieda1, K Yamaoka, T Ito, T Nakagawa.   

Abstract

PURPOSE: The local absorption kinetics of levofloxacin from the intestinal tract was quantitatively evaluated by simultaneously measuring the portal and venous plasma concentrations in a conscious rat.
METHODS: The venous and upper portal blood vessels were cannulated through the jugular and pyloric veins, respectively. After oral or intravenous administration of levofloxacin, portal and venous concentrations of levofloxacin were simultaneously monitored. The absorption rate from the intestine into the portal system was calculated from the portal-venous difference in the plasma concentration of levofloxacin, considering the distribution of levofloxacin into erythrocytes. Portal blood flow rate was newly measured by an electromagnetic flow meter.
RESULTS: There was little portal-venous difference after an intravenous dose of levofloxacin. In contrast, after oral administration, the plasma concentration in the portal vein was constantly higher than that in the jugular vein, demonstrating that this difference was caused by the intestinal absorption of levofloxacin.
CONCLUSIONS: Approximately 90% levofloxacin was absorbed as the intact form from the intestinal tract into the portal system. By considering the bioavailability of levofloxacin in rat, the hepatic extraction ratio in vivo of levofloxacin was estimated to be 30%. The mean local absorption time (Ta) was 1.44 hr which coincided almost with the mean absorption time (MAT).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8865312     DOI: 10.1023/a:1016012203496

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  Kinetic mechanism for the intestinal absorption of ofloxacin.

Authors:  J G Prieto; J P Barrio; A I Alvarez; G Gómez
Journal:  J Pharm Pharmacol       Date:  1988-03       Impact factor: 3.765

2.  Stereoselective glucuronidation of ofloxacin in rat liver microsomes.

Authors:  O Okazaki; T Kurata; H Hakusui; H Tachizawa
Journal:  Drug Metab Dispos       Date:  1991 Mar-Apr       Impact factor: 3.922

3.  Moment analysis for the separation of mean in vivo disintegration, dissolution, absorption, and disposition time of ampicillin products.

Authors:  Y Tanigawara; K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharm Sci       Date:  1982-10       Impact factor: 3.534

Review 4.  Ofloxacin clinical pharmacokinetics.

Authors:  K C Lamp; E M Bailey; M J Rybak
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

5.  Enantioselective disposition of ofloxacin in humans.

Authors:  O Okazaki; C Kojima; H Hakusui; M Nakashima
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

6.  Method to estimate the rate and extent of intestinal absorption in conscious rats using an absorption probe and portal blood sampling.

Authors:  D J Hoffman; T Seifert; A Borre; H N Nellans
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

7.  Evaluation of intestinal absorption into the portal system in enterohepatic circulation by measuring the difference in portal-venous blood concentrations of diclofenac.

Authors:  K Tabata; K Yamaoka; T Fukuyama; T Nakagawa
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

8.  In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin.

Authors:  K P Fu; S C Lafredo; B Foleno; D M Isaacson; J F Barrett; A J Tobia; M E Rosenthale
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

9.  Liver blood flow measurement in the rat. The electromagnetic versus the microsphere and the clearance methods.

Authors:  M J Daemen; H H Thijssen; H van Essen; H T Vervoort-Peters; F W Prinzen; H A Struyker Boudier; J F Smits
Journal:  J Pharmacol Methods       Date:  1989-07

10.  Physiological pharmacokinetics of ethoxybenzamide based on biochemical data obtained in vitro as well as on physiological data.

Authors:  J H Lin; Y Sugiyama; S Awazu; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1982-12
View more
  5 in total

1.  A physiologic model for simulating gastrointestinal flow and drug absorption in rats.

Authors:  Stefan Willmann; Walter Schmitt; Jörg Keldenich; Jennifer B Dressman
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

2.  Intranasal Delivery of Topically-Acting Levofloxacin to Rats: a Proof-of-Concept Pharmacokinetic Study.

Authors:  Joana Sousa; Gilberto Alves; Ana Fortuna; Amílcar Falcão
Journal:  Pharm Res       Date:  2017-07-26       Impact factor: 4.200

3.  Evaluation of capacity-limited first-pass effect through liver by three-points sampling in portal and hepatic veins and systemic artery.

Authors:  Shinya Ueda; Kiyoshi Yamaoka; Jyoji Yui; Akio Shigematsu; Terumichi Nakagawa
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

4.  Effect of coadministered uridine on intestinal first-pass metabolism of 5'-deoxy-5-fluorouridine in conscious rats--an evaluation by method of portal-systemic concentration difference.

Authors:  Y Sawai; K Yamaoka; T Nakagawa
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

5.  A recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference.

Authors:  Toshiya Moriwaki; Hiroyuki Yasui; Akira Yamamoto
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-04       Impact factor: 2.745

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.